The anti-tumor activity of TK216 is also observed in lymphoma, where it exerts its cytotoxic effects by disrupting the interaction between SpiB/Spi1 and RNA helicases, DDX5 and DHX9 [14]. The gene discussed is SPIB; the disease is lymphoma.